Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan 27:9:545-55.
doi: 10.2147/OTT.S95633. eCollection 2016.

Immunocompromised and immunocompetent mouse models for head and neck squamous cell carcinoma

Zhen-Ge Lei  1 , Xiao-Hua Ren  2 , Sha-Sha Wang  3 , Xin-Hua Liang  4 , Ya-Ling Tang  5
Affiliations
Review

Immunocompromised and immunocompetent mouse models for head and neck squamous cell carcinoma

Zhen-Ge Lei et al. Onco Targets Ther. .

Abstract

Mouse models can closely mimic human oral squamous epithelial carcinogenesis, greatly expand the in vivo research possibilities, and play a critical role in the development of diagnosis, monitoring, and treatment of head and neck squamous cell carcinoma. With the development of the recent research on the contribution of immunity/inflammation to cancer initiation and progression, mouse models have been divided into two categories, namely, immunocompromised and immunocompetent mouse models. And thus, this paper will review these two kinds of models applied in head and neck squamous cell carcinoma to provide a platform to understand the complicated histological, molecular, and genetic changes of oral squamous epithelial tumorigenesis.

Keywords: HNSCC; head and neck squamous cell carcinoma; immunocompetent models; immunocompromised models; mouse models; transgenic models.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mouse models of oral cancer. Abbreviations: NOD, nonobese diabetic; SCID, severe combined immunodeficiency; NSG, NOD/SCID gamma.
See this image and copyright information in PMC

References

    1. Haddad RI, Shin DM. Recent advances in head and neck cancer. N Engl J Med. 2008;359(11):1143–1154. - PubMed
    1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300. - PubMed
    1. Jung AC, Ray AM, Ramolu L, et al. Caveolin-1-negative head and neck squamous cell carcinoma primary tumors display increased epithelial to mesenchymal transition and prometastatic properties. Oncotarget. 2015 Oct 12;:Epub. - PMC - PubMed
    1. Leemans RL, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011;11(1):9–22. - PubMed
    1. Caligiuri I, Rizzolio F, Boffo S, et al. Critical choices for modeling breast cancer in transgenic mouse models. J Cell Physiol. 2012;227(8):2988–2991. - PubMed

LinkOut - more resources